Palvella Therapeutics, Inc. (PVLA) — DEF 14A Filings
All DEF 14A filings from Palvella Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Palvella Therapeutics Files Proxy Statement for Annual Meeting
— Apr 30, 2025 Risk: low
Palvella Therapeutics, Inc. (formerly Pieris Pharmaceuticals, Inc.) filed a DEF 14A proxy statement on April 30, 2025, for its annual meeting on June 10, 2025. -
Pieris Pharmaceuticals Files Definitive Proxy Statement
— Nov 6, 2024 Risk: low
Pieris Pharmaceuticals, Inc. filed its definitive proxy statement (DEF 14A) on November 6, 2024, for its fiscal year ending December 31, 2024. The filing pertai
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX